Overall Technical outlook

Price Summary

In today's trading session, GLAND's shares skyrocketed by 4.5%, marking a robust day.
Gland Pharma Limited's stock opened at 1815.8 on 2026-02-02, surged to a high of 1922.0, hit a low of 1798.6, and closed up 4.5% at 1897.5, with 258854 shares traded.
The highest price the stock achieved in the past 52 weeks is 2102.1, while the lowest price it saw is 1392.8.
12 analysts forecast that the price of GLAND will range from 1555.0 to 2360.0, with an average expected price near 1935.75.

Technicals

Support and Resistance: At 1897.5, the price for GLAND is supported at 1769.8 and resisted at 1957.5. This indicates a trading range where 1769.8 serves as a support level, potentially preventing further decline, while 1957.5 could limit upward movement.
GLAND supportResistance e6234b
Support/Resistance for GLAND


Aroon: The continuation of Aroon's bullish trend, with Aroon Up remaining at 100, signals strong momentum. However, to fully assess the trend's future potential, it should be analyzed in conjunction with other technical indicators.
GLAND aroon e6234b
Aroon chart for Gland Pharma Limited


Bol. Bands: In the latest price action, the current price has surpassed the upper Bollinger Band, indicating a bullish breakout. This upward movement suggests that the market is experiencing strong buying pressure, driving the price higher. Such a move is often seen as a sign of increasing momentum, potentially leading to continued upward movement.
GLAND bbands e6234b
Bolinger Bands chart for Gland Pharma Limited


Parabolic SAR: The PSAR continues to signal a bullish outlook, establishing a key support level that reinforces the market's upward momentum. This support could serve as a base for continued gains, suggesting that the bullish trend is likely to persist.
GLAND psar e6234b
Parabolic Stop and Reverse chart for Gland Pharma Limited


Stochastic: The stochastic indicator for GLAND shows a bullish signal, with the K-line positioned above the D-line and also above the 80 mark. This suggests strong upward momentum, indicating that the market may continue to trend higher. Traders might view this as a sign of continued strength and potential buying opportunities.
GLAND stoch e6234b
Stochastic chart for Gland Pharma Limited


Tripple Moving Agerage: The Tripple MOVING AVG is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
GLAND trippleSMA e6234b
Tripple SMA chart for Gland Pharma Limited


To derive valuable insights from a company's technical performance, it is essential to first understand its fundamentals. This includes its financial health, business model, and market share. Equally important is the industry context, such as competition, consumer demand, and market trends. By examining these aspects together, investors can gain a more comprehensive view of how the company's stock behaves and whether it's aligned with its underlying value.